SanaCurrents Quarterly Plan

SanaCurrents applies data points to assess how likely a company will be able to advance a drug or device, helping us to determine our decision to potentially buy the stock, which we disclose to members.

Account Information

First Name:

Last Name:

Username:

Email:

Password:

Phone (optional):

Twitter Username (optional, but highly recommended for Premium Alerts)

Billing Details

Credit Card:

Security Code:

Expiration Date:

Billing Address

Address:

City:

State:

Zip:

Country:

Shipping Address

Shipping Method:

Shipping is the same as billing

Address:

City:

State:

Zip :

Country:

SanaCurrents Quarterly Special

Quarterly SanaCurrents Subscription

- Product Price: 30 day trial for $7.99, $297.00 every 3 months

Today’s Charge:

Submit Order

What were some of the key approaches that led to SanaCurrents’ successful case studies?

Identifying the timing of binary events to determine when a stock will move.
Evaluating the track record of success in early trials of drug candidates.
Finding the management that is interested in advancing the a drug to approval – which often leads to a significant increase in stock value – instead of management that has been capitalized to fund exploratory research.
Determining the support of key opinion leaders for a specific drug or device.
Looking at past FDA actions.

Account Information

Billing Details

Billing Address

Shipping Address

SanaCurrents Quarterly Special

SanaCurrents Leaves Your BioTech Guesswork Behind